Nuvectis Pharma (NVCT) Shares Issued (2022 - 2026)

Nuvectis Pharma has disclosed Shares Issued across 5 years of filings, most recently posting $7000.0 for Q1 2026.

• Shares Issued for Q1 2026 came in at $7000.0, down 99.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.1 million (up 67.42% YoY), and the FY2025 annual result was $15.5 million, up 28.99% from the prior year.
• Shares Issued came in at $7000.0 for Q1 2026 at Nuvectis Pharma, down from $13.5 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $16.0 million in Q1 2022 to a low of -$121000.0 in Q3 2022.
• The 5-year median for Shares Issued is $1.4 million (2024), against an average of $3.9 million.
• Across the five-year window, Shares Issued surged 10614.29% in 2024 and sank 99.45% in 2026, its largest moves.
• Nuvectis Pharma's Shares Issued stood at $121000.0 in 2022, then sank by 88.43% to $14000.0 in 2023, then surged by 28135.71% to $4.0 million in 2024, then jumped by 241.51% to $13.5 million in 2025, then tumbled by 99.95% to $7000.0 in 2026.
• The last three Shares Issued figures came in at $7000.0 (Q1 2026), $13.5 million (Q3 2025), and $600000.0 (Q2 2025), per Business Quant data.